Médecins Sans Frontières Research

607 studies

88 locations

170 studies with recorded impact

Filter studies by...

Recently updated Recently created

Displaying all 4 studies

Protocol & ERB

Person-centred care (PCC) to improve DR-TB treatment outcomes: Assessing a multidisciplinary psychosocial support (PS) and harm reduction intervention in a cohort of MDR/RR-TB patients with harmful use of alcohol in Minsk, Belarus

Study details: Mixed-methods study in Belarus

Principal investigator: Isidro Carrion

Latest update: Protocol & ERB | 17th December 2021
Concept

Implementation of all oral 24 weeks regimen for DR-TB patients

Study details: Other in South Sudan , Uzbekistan , Afghanistan , Belarus , Libya , Russian Federation , Sierra Leone , Somalia , South Africa , Tajikistan

Latest update:
Concept paper added by Animesh Sinha
| 18th June 2021
Protocol & ERB

endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB with regimens containing bedaquiline or delamanid

Study details: Observational study in Bangladesh , Ethiopia , Armenia , Belarus , Georgia , Indonesia , Kazakhstan , Kenya , Kyrgyzstan , Lesotho , Myanmar , Nepal , Pakistan , Peru , South Africa

Principal investigator: Helena Huerga

Latest update: Principal investigator changed by Holly Baker | 27th May 2020
Implementation

TB- PRACTECAL: A randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug resistant tuberculosis.

Study details: Randomised controlled trial (RCT) in Uzbekistan , Belarus

Principal investigator: Bern-Thomas Nyang'wa

Latest update:
Formal working group, expert panel, advisory body dissemination added by Bern-Thomas Nyang'wa
| 24th September 2018

Impact: External Policy added by Bern-thomas nyang'wa | 15th Nov 2016

Include archived

Cancel

Afghanistan
Armenia
Australia
Bangladesh
Belarus
Belgium
Bhutan
Burkina Faso
Burundi
Cambodia
Cameroon
Central African Republic
Chad
Congo (Democratic Republic of the)
Ethiopia
Georgia
Greece
Guinea
Guinea-Bissau
Haiti
Honduras
India
Indonesia
Iraq
Italy
Jordan
Kazakhstan
Kenya
Kyrgyzstan
Lebanon
Lesotho
Liberia
Libya
Madagascar
Malawi
Malaysia
Mauritania
Mozambique
Myanmar
Nepal
Netherlands
Niger
Nigeria
Pakistan
Palestine, State of
Papua New Guinea
Peru
Philippines
Russian Federation
Serbia
Sierra Leone
Somalia
South Africa
South Sudan
Spain
Sudan
Sweden
Syrian Arab Republic
Tajikistan
Turkey
Uganda
Ukraine
United Kingdom of Great Britain and Northern Ireland
Uzbekistan
Venezuela (Bolivarian Republic of)
Yemen
Zimbabwe
eSwatini

Accessibility to health
AMR
Cholera
Ebola
Environmental contamination
Heavy metal poisoning
Hepatitis E
HIV/AIDS
Leishmaniasis
Malaria
Management of patients with severe head trauma
Maternal & womens health
Measles
Meningitis
Mental health
Mortality
Neonatal and child health
Non-communicable diseases
NTDs (excluding leishmaniasis)
Nutrition
OCB-Management of Head Trauma Patients
Other
Pneumonia
Sexual violence
Surgery
Tuberculosis
Vaccination
Viral haemorraghic fever (excluding Ebola)
Water & sanitation

Médecins Sans Frontières Research

Person-centred care (PCC) to improve DR-TB treatment outcomes: Assessing a multidisciplinary psychosocial support (PS) and harm reduction intervention in a cohort of MDR/RR-TB patients with harmful use of alcohol in Minsk, Belarus

Implementation of all oral 24 weeks regimen for DR-TB patients

endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB with regimens containing bedaquiline or delamanid

TB- PRACTECAL: A randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug resistant tuberculosis.